For locally advanced cancers (stage 3), observed survival was slightly higher for people living in Major Cities compared to Inner and Outer regional areas at 1 year (92% compared to 89%) and 3 years from diagnosis (75% compared to 70%). For metastatic cancers (stage 4), observed survival was slightly higher for people living in Major Cities compared to Inner and Outer regional areas at 3 years from diagnosis (23% compared to 17%). For locally advanced cancers (stage 3), observed survival was slightly higher among people living in the highest SES areas (SES5, 95%) compared to lower SES areas (SES1-4, between 89% and 91%); and in the highest SES areas (SES5, 77%) compared to the lowest SES areas (SES1, 69%).